ABBOTT LABORATORIES (ABT) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues
U.S.				10,839.0	9,673.0
Diagnostics	15,644.0	10,805.0	7,713.0	7,495.0	5,616.0		4,646.0	4,721.0
Nutritionals	8,294.0	7,647.0	7,409.0	7,229.0	6,925.0		6,975.0	6,953.0
Established Pharmaceuticals	4,718.0	4,303.0	4,486.0	4,422.0	4,287.0		3,720.0	3,118.0
Other				62.0	237.0		2,272.0	2,469.0
Vascular								2,986.0

EBITDA
Diagnostics	6,256.0	3,725.0	1,912.0	1,868.0	1,468.0	1,194.0	1,171.0	1,079.0
Nutritionals	1,763.0	1,751.0	1,705.0	1,652.0	1,589.0	1,660.0	1,741.0	1,459.0
Established Pharmaceuticals	889.0	794.0	904.0	894.0	848.0	723.0	658.0	624.0
Vascular								1,091.0
Corporate								439.0

EBIT
Diagnostics	6,256.0	3,725.0	1,912.0	1,868.0	1,468.0	1,194.0	1,171.0	1,079.0
Nutritionals	1,763.0	1,751.0	1,705.0	1,652.0	1,589.0	1,660.0	1,741.0	1,459.0
Established Pharmaceuticals	889.0	794.0	904.0	894.0	848.0	723.0	658.0	624.0
Vascular								1,091.0
Corporate								439.0

Mix
U.S.				35.4%	35.3%
Diagnostics	36.3%	31.2%	24.2%	24.5%	20.5%		22.8%	23.3%
Nutritionals	19.3%	22.1%	23.2%	23.6%	25.3%		34.2%	34.3%
Established Pharmaceuticals	11.0%	12.4%	14.1%	14.5%	15.7%		18.2%	15.4%
Other				0.2%	0.9%		11.1%	12.2%
Vascular								14.7%

Growth
U.S.				12.1%
Diagnostics	44.8%	40.1%	2.9%	33.5%			-1.6%	3.9%
Nutritionals	8.5%	3.2%	2.5%	4.4%			0.3%	3.2%
Established Pharmaceuticals	9.6%	-4.1%	1.4%	3.1%			19.3%	8.9%
Other				-73.8%			-8.0%	-1.2%
Vascular								-0.9%